NASDAQ: ACLX
Arcellx Inc Stock Ownership - Who owns Arcellx?

Insider buying vs selling

Have Arcellx Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Christopher HeeryCHIEF MEDICAL OFFICER2026-01-145,882$68.51
$403.00kSell
Christopher HeeryCHIEF MEDICAL OFFICER2026-01-137,437$65.51
$487.21kSell
Christopher HeeryCHIEF MEDICAL OFFICER2026-01-126,131$64.15
$393.29kSell
Christopher HeeryCHIEF MEDICAL OFFICER2025-11-17340$90.00
$30.60kSell
Michelle GilsonCHIEF FINANCIAL OFFICER2025-10-155,364$91.04
$488.32kSell
Michelle GilsonCHIEF FINANCIAL OFFICER2025-10-061,064$86.22
$91.73kSell
Michelle GilsonCHIEF FINANCIAL OFFICER2025-10-034,882$86.00
$419.87kSell
Christopher HeeryCHIEF MEDICAL OFFICER2025-09-301,530$82.20
$125.76kSell
Christopher HeeryCHIEF MEDICAL OFFICER2025-09-305,300$80.55
$426.93kSell
Christopher HeeryCHIEF MEDICAL OFFICER2025-09-3014,204$81.46
$1.16MSell

1 of 4

ACLX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ACLX insiders and whales buy or sell their stock.

ACLX Shareholders

What type of owners hold Arcellx Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Gilead Sciences Inc11.62%6,720,803$463.33MInsider
Gilead Sciences Inc11.62%6,720,803$463.33MInstitution
Sr One Capital Management LLC11.28%6,520,370$449.51MInsider
T Rowe Price Investment Management Inc10.99%6,352,356$437.93MInstitution
Jill Carroll10.97%6,340,738$437.13MInsider
Fmr LLC9.96%5,761,317$397.19MInstitution
Scott D. Sandell8.21%4,748,116$327.34MInsider
Peter W. Sonsini8.21%4,746,083$327.19MInsider
Mohamad Makhzoumi8.21%4,745,545$327.16MInsider
Anthony A. Florence Jr.8.21%4,745,262$327.14MInsider

1 of 3

ACLX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ACLX51.32%48.68%Net SellingNet Selling
LEGN22.65%0.00%
ADMA79.67%20.33%Net SellingNet Selling
VKTX63.02%9.09%Net SellingNet Selling
LGND18.29%81.71%Net SellingNet Selling

Arcellx Stock Ownership FAQ

Who owns Arcellx?

Arcellx (NASDAQ: ACLX) is owned by 109.06% institutional shareholders, 103.45% Arcellx insiders, and 0.00% retail investors. Gilead Sciences Inc is the largest individual Arcellx shareholder, owning 6.72M shares representing 11.62% of the company. Gilead Sciences Inc's Arcellx shares are currently valued at $463.33M.

If you're new to stock investing, here's how to buy Arcellx stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.